Rtw Investments, LP Dyne Therapeutics, Inc. Transaction History
Rtw Investments, LP
- $6.27 Billion
- Q3 2024
A detailed history of Rtw Investments, LP transactions in Dyne Therapeutics, Inc. stock. As of the latest transaction made, Rtw Investments, LP holds 6,818,641 shares of DYN stock, worth $164 Million. This represents 3.9% of its overall portfolio holdings.
Number of Shares
6,818,641
Previous 6,387,138
6.76%
Holding current value
$164 Million
Previous $225 Million
8.66%
% of portfolio
3.9%
Previous 3.76%
Shares
3 transactions
Others Institutions Holding DYN
# of Institutions
209Shares Held
102MCall Options Held
234KPut Options Held
238K-
Atlas Venture Life Science Advisors, LLC8.02MShares$192 Million35.54% of portfolio
-
Black Rock Inc. New York, NY7.39MShares$177 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.86MShares$165 Million0.0% of portfolio
-
Janus Henderson Group PLC London, X06.81MShares$163 Million0.13% of portfolio
-
Ra Capital Management, L.P. Boston, MA6.38MShares$153 Million3.2% of portfolio
About Dyne Therapeutics, Inc.
- Ticker DYN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 51,765,400
- Market Cap $1.24B
- Description
- Dyne Therapeutics, Inc., a muscle disease company, operates as a biotechnology company that focuses on advancing therapeutics for genetically driven muscle diseases in the United States. It develops various programs for myotonic dystrophy type 1, duchenne muscular dystrophy, and facioscapulohumeral dystrophy, as well as rare skeletal muscle, and...